RenovoRx, Inc.
Key Metrics
Market Snapshot
About
RenovoRx is a clinical-stage biopharmaceutical company developing targeted combination therapies for high unmet medical need cancers. The company focuses on intra-arterial delivery technology that enables localized, intensive treatment of tumors while minimizing systemic exposure. RenovoRx is advancing its pipeline with a focus on pancreatic cancer and other solid tumors.